Surmodics Revenue 2010-2025 | SRDX

Surmodics revenue from 2010 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Surmodics Annual Revenue
(Millions of US $)
2024 $126
2023 $133
2022 $100
2021 $105
2020 $95
2019 $100
2018 $81
2017 $73
2016 $71
2015 $62
2014 $57
2013 $56
2012 $52
2011 $53
2010 $54
2009 $122
Surmodics Quarterly Revenue
(Millions of US $)
2025-03-31 $28
2024-12-31 $30
2024-09-30 $33
2024-06-30 $30
2024-03-31 $32
2023-12-31 $31
2023-09-30 $28
2023-06-30 $52
2023-03-31 $27
2022-12-31 $25
2022-09-30 $26
2022-06-30 $25
2022-03-31 $26
2021-12-31 $23
2021-09-30 $24
2021-06-30 $24
2021-03-31 $35
2020-12-31 $22
2020-09-30 $23
2020-06-30 $27
2020-03-31 $23
2019-12-31 $23
2019-09-30 $31
2019-06-30 $24
2019-03-31 $23
2018-12-31 $22
2018-09-30 $23
2018-06-30 $22
2018-03-31 $19
2017-12-31 $17
2017-09-30 $20
2017-06-30 $18
2017-03-31 $18
2016-12-31 $18
2016-09-30 $18
2016-06-30 $20
2016-03-31 $17
2015-12-31 $17
2015-09-30 $17
2015-06-30 $16
2015-03-31 $14
2014-12-31 $14
2014-09-30 $15
2014-06-30 $15
2014-03-31 $14
2013-12-31 $14
2013-09-30 $14
2013-06-30 $14
2013-03-31 $14
2012-12-31 $14
2012-09-30 $14
2012-06-30 $14
2012-03-31 $12
2011-12-31 $12
2011-09-30 $14
2011-06-30 $13
2011-03-31 $13
2010-12-31 $13
2010-09-30 $16
2010-06-30 $19
2010-03-31 $18
2009-12-31 $17
2009-09-30 $19
2009-06-30 $18
2009-03-31 $21
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.524B $0.126B
Surmodics is a leading provider of medical device and In Vitro Diagnostics (IVD) technologies to the healthcare industry. It reports through two divisions: Medical Devices & IVD.?The Medical Devices segment comprises surface modification coating technologies to improve access, deliverability, and predictable deployment of medical devices, international cardiology and peripheral balloon design, development and manufacturing, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device, with end markets that include coronary, peripheral, neuro-vascular and urology, among others. The IVD segment includes component products and technologies for diagnostic test kits and biomedical research applications, with products that include protein stabilization reagents, substrates, antigens and surface coatings.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $219.828B 25.79
Boston Scientific (BSX) United States $156.585B 37.40
Stryker (SYK) United States $152.939B 31.98
EssilorLuxottica (ESLOY) France $137.925B 0.00
Medtronic (MDT) Ireland $117.956B 16.72
Lonza Group Ag (LZAGY) Switzerland $49.343B 0.00
Haleon (HLN) United Kingdom $43.576B 24.87
ResMed (RMD) United States $40.103B 30.12
GE HealthCare Technologies (GEHC) United States $35.596B 16.90
Agilent Technologies (A) United States $33.957B 22.14
Terumo (TRUMY) Japan $25.643B 33.31
Koninklijke Philips (PHG) Netherlands $24.709B 17.34
Insulet (PODD) United States $20.568B 80.74
Zimmer Biomet Holdings (ZBH) United States $18.989B 12.20
Baxter (BAX) United States $14.636B 10.93
Smith & Nephew SNATS (SNN) United Kingdom $13.656B 0.00
Sunny Optical Technology (SNPTF) China $10.417B 0.00
Demant (WILYY) Denmark $8.633B 0.00
Bio-Rad Laboratories (BIO) United States $6.891B 23.98
Lantheus Holdings (LNTH) United States $5.010B 12.64
Perrigo (PRGO) Ireland $3.867B 9.80
Prestige Consumer Healthcare (PBH) United States $3.770B 16.84
Haemonetics (HAE) United States $3.587B 16.34
Envista Holdings (NVST) United States $3.515B 29.21
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.138B 23.14
LeMaitre Vascular (LMAT) United States $1.863B 41.65
QuidelOrtho (QDEL) United States $1.764B 12.14
AtriCure (ATRC) United States $1.645B 0.00
Acuren (TIC) United States $1.367B 0.00
Green Thumb Industries (GTBIF) United States $1.332B 29.96
AdaptHealth (AHCO) United States $1.294B 13.14
Neogen (NEOG) United States $1.176B 15.06
Phibro Animal Health (PAHC) United States $1.172B 14.98
BioLife Solutions (BLFS) United States $1.063B 0.00
Curaleaf Holdings (CURLF) Canada $0.987B 0.00
InMode (INMD) Israel $0.919B 9.26
Kestra Medical Technologies (KMTS) United States $0.847B 0.00
Tilray Brands (TLRY) Canada $0.704B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.675B 0.00
Valneva SE (VALN) France $0.648B 0.00
Owens & Minor (OMI) United States $0.608B 5.04
Evolus (EOLS) United States $0.598B 0.00
CeriBell (CBLL) United States $0.541B 0.00
ZimVie (ZIMV) United States $0.524B 23.82
SNDL (SNDL) Canada $0.394B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.358B 0.00
Cresco Labs (CRLBF) United States $0.329B 0.00
VAREX IMAGING (VREX) United States $0.325B 11.97
Quanterix (QTRX) United States $0.324B 0.00
Capricor Therapeutics (CAPR) United States $0.310B 0.00
Sanuwave Health (SNWV) United States $0.306B 0.00
Aurora Cannabis (ACB) Canada $0.269B 79.67
Cerus (CERS) United States $0.260B 0.00
Omeros (OMER) United States $0.256B 0.00
OraSure Technologies (OSUR) United States $0.251B 0.00
Viemed Healthcare (VMD) United States $0.246B 20.77
Biote (BTMD) United States $0.239B 6.72
Verano Holdings (VRNOF) United States $0.238B 0.00
Brainsway (BWAY) Israel $0.227B 60.00
Canopy Growth (CGC) Canada $0.224B 0.00
Sanara MedTech (SMTI) United States $0.222B 0.00
Organigram Global (OGI) Canada $0.198B 0.00
Utah Medical Products (UTMD) United States $0.188B 15.45
High Tide (HITI) Canada $0.184B 0.00
TriSalus Life Sciences (TLSI) United States $0.172B 0.00
Vireo Growth (VREOF) United States $0.170B 0.00
Exagen (XGN) United States $0.157B 0.00
TerrAscend (TSNDF) Canada $0.138B 0.00
FitLife Brands (FTLF) United States $0.120B 14.83
MacroGenics (MGNX) United States $0.105B 0.00
Jushi Holdings (JUSHF) United States $0.104B 0.00
Jin Medical (ZJYL) China $0.104B 0.00
Fonar (FONR) United States $0.099B 12.77
Quipt Home Medical (QIPT) United States $0.093B 0.00
Apyx Medical (APYX) United States $0.091B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.090B 0.00
Safety Shot (SHOT) United States $0.088B 0.00
Zynex (ZYXI) United States $0.077B 0.00
Veru (VERU) United States $0.077B 0.00
InterCure (INCR) Israel $0.069B 0.00
Agape ATP (ATPC) $0.067B 0.00
ImmuCell (ICCC) United States $0.060B 0.00
Cytosorbents (CTSO) United States $0.059B 0.00
United-Guardian (UG) United States $0.039B 13.38
Nephros (NEPH) United States $0.038B 51.43
Modular Medical (MODD) United States $0.038B 0.00
Rockwell Medical (RMTI) United States $0.035B 0.00
Allurion Technologies (ALUR) United States $0.022B 0.00
INLIF (INLF) $0.015B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Meihua Medical Technologies (MHUA) China $0.012B 0.00
Senestech (SNES) United States $0.012B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
IM Cannabis (IMCC) Canada $0.011B 0.00
Innovative Eyewear (LUCY) United States $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00